Literature DB >> 24265928

Pathotyping bla CTX-M Escherichia coli from Nigeria.

Olugbenga Adekunle Olowe, Suman Choudhary, Peter Schierack, Lothar H Wieler, Olufunmilola Bamidele Makanjuola, Albert B Olayemi, Muna Anjum.   

Abstract

BACKGROUND: Escherichia coli have become the enterobacteriaceae species most affected by extended-spectrum β-lactamases (ESBLs) in view of the emergence of CTX-M-type ESBLs. These CTX-M-positive E. coli have been reported in numerous regions worldwide. Virulence determinants of already reported CTX-M-positive E. coli were investigated.
METHODOLOGY: To gain insights into the mechanism underlying this phenomenon, we assessed serogroup, susceptibility pattern and diversity of virulence profiles within a collection of nine bla CTX-M-positive E. coli strains and their virulent determinant using miniaturized DNA microarray techniques. The nine ESBL-positive E. coli isolates were from eight male and one female patient(s) selected for study based on previous work. Virulence potential was inferred by detection of 63 virulence factor (VF) genes.
RESULTS: Four (44.4%) of the 9 E. coli isolates exhibited the same set of core characteristics: serotype O8:Hnt, while all were positive for OXA-1, ciprofloxacin resistance. Five of the isolates exhibited highly similar (91% to 100%) VF profiles.
CONCLUSION: The findings describe a broadly disseminated, bla CTX-M-positive and virulent E. coli serogroup with highly homogeneous virulence genotypes, suggesting recent emergence in this zone. Understanding how this clone has emerged and successfully disseminated within the hospital and community, including across national boundaries, should be a public health priority.

Entities:  

Keywords:  blaCTX-M-positive, virulent E. coli, miniaturized DNA microarray, pathotyping, resistance

Year:  2013        PMID: 24265928      PMCID: PMC3832090          DOI: 10.1556/EuJMI.3.2013.2.5

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  26 in total

1.  Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays.

Authors:  S Monecke; R Ehricht
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

Review 2.  Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.

Authors:  Johann D D Pitout; Patrice Nordmann; Kevin B Laupland; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

Review 3.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Microarray analysis of microbial virulence factors.

Authors:  V Chizhikov; A Rasooly; K Chumakov; D D Levy
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

6.  Development and validation of an oligonucleotide microarray for detection of multiple virulence and antimicrobial resistance genes in Escherichia coli.

Authors:  Guillaume Bruant; Christine Maynard; Sadjia Bekal; Isabelle Gaucher; Luke Masson; Roland Brousseau; Josée Harel
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  PCR for detection of cdt-III and the relative frequencies of cytolethal distending toxin variant-producing Escherichia coli isolates from humans and cattle.

Authors:  Clifford G Clark; Shelley T Johnson; Russell H Easy; Jennifer L Campbell; Frank G Rodgers
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Genetic background of Escherichia coli and extended-spectrum beta-lactamase type.

Authors:  Catherine Branger; Oana Zamfir; Sabine Geoffroy; Geneviève Laurans; Guillaume Arlet; Hoang Vu Thien; Stéphanie Gouriou; Bertrand Picard; Erick Denamur
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more
  1 in total

1.  Multidrug Resistance of Acinetobacter Baumannii in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria.

Authors:  G Odewale; O J Adefioye; J Ojo; F A Adewumi; O A Olowe
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.